Adjuvant vs. progression-triggered treatment with gemcitabine after   radical cystectomy in platinum-ineligible patients with pT3-pT4 or N+M0   urothelial carcinoma of the bladder (AUO-AB 22-00): Long-term follow-up   of a randomized multicenter phase 3 trial

Title:: Adjuvant vs. progression-triggered treatment with gemcitabine after radical cystectomy in platinum-ineligible patients with pT3-pT4 or N+M0 urothelial carcinoma of the bladder (AUO-AB 22-00): Long-term follow-up of a randomized multicenter phase 3 trial
Document type:: Meeting Abstract
Author(s):: Heinzelbecker, J.; Spieler, N.; Kuehn, M.; Fischer, C.; Volkmer, B.; Von Rundstedt, F-C.; Albers, P.; Becht, E.; Bannowsky, A.; Weber, H. M.; Hofmann, R.; Mueller, M.; Langbein, S.; Steiner, G.; Retz, M.; Kamradt, J.; Wellek, S.; Lehmann, J.; Stoeckle, M.
Journal title abbreviation:: Eur Urol
Year:: 2021
Journal volume:: 79 Suppl 1
Pages contribution:: S1152-S1153
Print-ISSN:: 0302-2838
TUM Institution:: Urologische Klinik und Poliklinik
BibTeX

Occurrences: